Dupilumab-PEdiatric skin barrier function and LIpidomics STudy in patients with Atopic Dermatitis

Trial Identifier: LPS16764
Sponsor: sanofi
Collaborator:
Regeneron Pharmaceuticals
Start Date: February 2021
Primary Completion Date: September 2022
Study Completion Date: November 2022
Condition: Eczema

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United Kingdom, Sheffield Sheffield, United Kingdom, S10 2TH
United States, California Los Angeles, California, United States, 90027
United States, Colorado Denver, Colorado, United States, 80206